Neurology and Neurosurgery - Global Neurology Academy

65-80 of 481

Practical Perspectives in Myasthenia Gravis #2: Patient Stratification and Antibody Profiling—Personalizing the Disease Lens
Practical Perspectives in Myasthenia Gravis #2: Patient Stratification and Antibody Profiling—Personalizing the Disease Lens
CME/CE
Practical Perspectives in Myasthenia Gravis #2: Patient Stratification and Antibody Profiling—Personalizing the Disease Lens
Diana Castro, MD; Jonathan Strober, MD
0.25 credits
- Diana Castro, MD
- Jonathan Strober, MD
0.25 credits
Cracking the Migraine Code: How AI May Transform Diagnosis and Treatment
Cracking the Migraine Code: How AI May Transform Diagnosis and Treatment
On the Frontlines of Migraine
Cracking the Migraine Code: How AI May Transform Diagnosis and Treatment
Ashley Baker, MSN, PMHNP; Chia-Chun Chiang, MD
- Ashley Baker, MSN, PMHNP
- Chia-Chun Chiang, MD
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
CME/CE
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
Emily D. Clark, DO; Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA
1.00 credit
- Emily D. Clark, DO
- Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA
- Susan Scanland, MSN, CRNP, GNP-BC, CDP
- Anthony J. Viera, MD, MPH
1.00 credit
Challenges and Opportunities in Migraine Management
Challenges and Opportunities in Migraine Management
Global Neurology Academy
Challenges and Opportunities in Migraine Management
Charles Turck, PharmD, BCPS, BCCCP; Yulia Orlova, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Yulia Orlova, MD
How Daily Light Habits Influence Migraine in Adolescents
How Daily Light Habits Influence Migraine in Adolescents
Global Neurology Academy
How Daily Light Habits Influence Migraine in Adolescents
Charles Turck, PharmD, BCPS, BCCCP; Carlyn Patterson Gentile, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Carlyn Patterson Gentile, MD
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Project Oncology®
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Alexandria May, PharmD, BCPS; Nicholas Whipple, MD, MPH
- Alexandria May, PharmD, BCPS
- Nicholas Whipple, MD, MPH
Endogenous Pathways in Migraine Care: Harnessing the Body's Natural Systems
Endogenous Pathways in Migraine Care: Harnessing the Body's Natural Systems
Global Neurology Academy
Endogenous Pathways in Migraine Care: Harnessing the Body's Natural Systems
Ashley Baker, MSN, PMHNP; Adriana Della Pietra, MD
- Ashley Baker, MSN, PMHNP
- Adriana Della Pietra, MD
New Pathways in the Treatment of DMD
New Pathways in the Treatment of DMD
CME/CE
New Pathways in the Treatment of DMD
Erika Finanger, MD, MS; Aravindhan Veerapandiyan, MD
1.00 credit
- Erika Finanger, MD, MS
- Aravindhan Veerapandiyan, MD
1.00 credit
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
NeuroFrontiers
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
Charles Turck, PharmD, BCPS, BCCCP; Desiree Matthews, PMHNP-BC
- Charles Turck, PharmD, BCPS, BCCCP
- Desiree Matthews, PMHNP-BC
Bridging the Diagnostic Gap: Blood Biomarkers in Alzheimer’s Care
Bridging the Diagnostic Gap: Blood Biomarkers in Alzheimer’s Care
NeuroFrontiers
Bridging the Diagnostic Gap: Blood Biomarkers in Alzheimer’s Care
Ashvini Keshavan, MRCP, PhD
- Ashvini Keshavan, MRCP, PhD
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
NeuroFrontiers
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
Shelina Ramnarine, PhD; Michelle Scargle, MD
- Shelina Ramnarine, PhD
- Michelle Scargle, MD
- Margaret Emerson, DNP, APRN, PMHNP-BC
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
On the Frontlines of Schizophrenia
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
Brian P. McDonough, MD, FAAFP; Ahmed Makhlouf, MD
- Brian P. McDonough, MD, FAAFP
- Ahmed Makhlouf, MD
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
NeuroFrontiers
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
Charles Turck, PharmD, BCPS, BCCCP; Ragy R. Girgis, MD, MS
- Charles Turck, PharmD, BCPS, BCCCP
- Ragy R. Girgis, MD, MS
- Desiree Matthews, PMHNP-BC
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
NeuroFrontiers
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
Hamid Abuwarda, PhD, BS
- Hamid Abuwarda, PhD, BS
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
NeuroFrontiers
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
Sharon Sha, MD, MS
- Sharon Sha, MD, MS
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
NeuroFrontiers
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
Charles Turck, PharmD, BCPS, BCCCP; David Kimhy, PhD
- Charles Turck, PharmD, BCPS, BCCCP
- David Kimhy, PhD

5/10